In patients with thromboinflammatory disorders, such as sepsis, cancer-associated thrombosis, or autoimmune vasculopathies, the dysregulated production of IL-6 and FgDPs may simultaneously promote a hypercoagulable state and maladaptive thrombopoiesis. The gene discussed is IL6; the disease is Venous thrombosis.